{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:51:33Z","timestamp":1792086693135,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To quantify bladder wall relaxation times in men without and with lower urinary tract symptoms (LUTS) using three-dimensional (3D) magnetic resonance fingerprinting (MRF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Following informed consent, 51 men (mean age 68.2 years, range 46\u201380) on active surveillance for prostate cancer underwent multiparametric MRI that included an investigational 3D MRF sequence. Anterior bladder wall T\n                      <jats:sub>1<\/jats:sub>\n                      and T\n                      <jats:sub>2<\/jats:sub>\n                      relaxation times were measured from the quantitative maps. Anterior bladder wall thickness (BWT) was measured and prostate and transition zone (TZ) volumes were estimated, from the conventional T2w images. Body mass index (BMI), LUTS scores (AUA-SI), risk factors for metabolic syndrome, history of diabetes (DM), and medications prescribed for LUTS were documented from the electronic medical record. The Kruskal-Wallis rank sum test, Wilcoxon rank sum exact test, and Fisher\u2019s exact test were used to assess the associations between clinical variables, categorical imaging data, and mean T\n                      <jats:sub>1<\/jats:sub>\n                      and T\n                      <jats:sub>2<\/jats:sub>\n                      relaxation times.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Native bladder wall T\n                      <jats:sub>1<\/jats:sub>\n                      relaxation times were longer in men with higher AUA-SI scores [AUA-SI 0\u20137: 1,496 ms vs. AUA-SI 8\u201320: 1,787 ms vs. AUA-SI 21\u201335: 2,063 ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03] while native bladder wall T\n                      <jats:sub>2<\/jats:sub>\n                      relaxation times were similar [AUA-SI 0\u20137: 67 ms vs. AUA-SI 8\u201320: 78 ms vs. AUA-SI 21\u201335: 122 ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.3]. Native bladder wall T\n                      <jats:sub>1<\/jats:sub>\n                      relaxation times were shorter in diabetic men compared to non-diabetic men (1239 ms vs. 1633 ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while T\n                      <jats:sub>2<\/jats:sub>\n                      relaxation times were similar (86 ms vs. 62 ms,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.4). Prostate and TZ volume, and BWT were similar in men without and with LUTS and DM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>3D MRF of the bladder is feasible, provides in-vivo tissue characterization of the bladder wall in men with LUTS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00261-026-05428-x","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:58:49Z","timestamp":1777694329000},"page":"5694-5701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Magnetic resonance fingerprinting of the bladder is feasible in men with lower urinary tract symptoms"],"prefix":"10.1007","volume":"51","author":[{"given":"Aymen","family":"Bahsoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Brace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamila","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gulani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Seiberlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hero","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"3","key":"5428_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474\u2013479. https:\/\/doi.org\/10.1016\/s0022-5347(17)49698-4","journal-title":"J Urol"},{"issue":"4","key":"5428_CR2","doi-asserted-by":"publisher","first-page":"443-vi","DOI":"10.1016\/j.ucl.2009.07.004","volume":"36","author":"GB Auffenberg","year":"2009","unstructured":"Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin North Am. 2009;36(4):443-vi. https:\/\/doi.org\/10.1016\/j.ucl.2009.07.004","journal-title":"Urol Clin North Am"},{"key":"5428_CR3","doi-asserted-by":"publisher","unstructured":"Fusco F, Creta M, De Nunzio C, et al. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018;18(1):15. https:\/\/doi.org\/10.1186\/s12894-018-0329-4.","DOI":"10.1186\/s12894-018-0329-4"},{"issue":"3","key":"5428_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.urology.2015.06.023","volume":"86","author":"\u00d6 G\u00fczel","year":"2015","unstructured":"G\u00fczel \u00d6, Aslan Y, Balc\u0131 M, et al. Can Bladder Wall Thickness Measurement Be Used for Detecting Bladder Outlet Obstruction?. Urology. 2015;86(3):439\u2013444. https:\/\/doi.org\/10.1016\/j.urology.2015.06.023","journal-title":"Urology"},{"key":"5428_CR5","doi-asserted-by":"publisher","unstructured":"Ma D, Gulani V, Seiberlich N, et al. Magnetic resonance fingerprinting. Nature. 2013;495(7440):187\u2013192. Magn Reson Med. 2017;77(4):1446\u20131458. https:\/\/doi.org\/10.1038\/nature11971","DOI":"10.1038\/nature11971"},{"key":"5428_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1532-429X-11-56","volume":"11","author":"S Giri","year":"2009","unstructured":"Giri, S., Chung, YC., Merchant, A. et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56 (2009). https:\/\/doi.org\/10.1186\/1532-429X-11-56","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"5428_CR7","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/mrm.29091","volume":"87","author":"C Velasco","year":"2022","unstructured":"Velasco C, Cruz G, Lavin B, et al. Simultaneous T1, T2, and T1\u03c1 cardiac magnetic resonance fingerprinting for contrast agent-free myocardial tissue characterization. Magn Reson Med. 2022;87(4):1992\u20132002. https:\/\/doi.org\/10.1002\/mrm.29091","journal-title":"Magn Reson Med"},{"issue":"13","key":"5428_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/heartjnl-2012-303052","volume":"99","author":"S Bull","year":"2013","unstructured":"Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932\u2013937. https:\/\/doi.org\/10.1136\/heartjnl-2012-303052","journal-title":"Heart"},{"issue":"1","key":"5428_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1532-429X-14-37","volume":"14","author":"WRT Witschey","year":"2012","unstructured":"Witschey WRT, Zsido GA, Koomalsingh K, et al. In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14(1):37. https:\/\/doi.org\/10.1186\/1532-429X-14-37","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1 Pt 1","key":"5428_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, et al. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):69\u201380. https:\/\/doi.org\/10.1016\/j.jcmg.2019.03.026","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"5428_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","volume":"6","author":"DM Sado","year":"2013","unstructured":"Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6(3):392\u2013398. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000070","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Suppl 1","key":"5428_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10286-019-00627-7","volume":"29","author":"I Bentellis","year":"2019","unstructured":"Bentellis I, Amarenco G, Gam\u00e9 X, et al. Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis. Clin Auton Res. 2019;29(Suppl 1):65\u201374. https:\/\/doi.org\/10.1007\/s10286-019-00627-7","journal-title":"Clin Auton Res"},{"issue":"8","key":"5428_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/RLI.0000000000000975","volume":"58","author":"S Gaur","year":"2023","unstructured":"Gaur S, Panda A, Fajardo JE, Hamilton J, Jiang Y, Gulani V. Magnetic resonance fingerprinting: a review of clinical applications. Invest Radiol. 2023;58(8):561\u2013577. https:\/\/doi.org\/10.1097\/RLI.0000000000000975","journal-title":"Invest Radiol"},{"issue":"6","key":"5428_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/mrm.25559","volume":"74","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Ma D, Seiberlich N, Gulani V, Griswold MA. MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout. Magn Reson Med. 2015;74(6):1621\u20131631. https:\/\/doi.org\/10.1002\/mrm.25559.","journal-title":"Magn Reson Med"},{"key":"5428_CR15","unstructured":"Fajardo J.E., Yang, J., Kaur T., Seiberlich, N. Gulani, V. Jiang Y. Accelerated MR Fingerprinting with 1 mm3 spatial resolution for prostate cancer at 3.0 T Proc. Intl. Soc. Mag. Reson. Med. 2024; 32(33\u201338)."},{"issue":"2","key":"5428_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/mrm.22423","volume":"64","author":"S Chung","year":"2010","unstructured":"Chung, S., Kim, D., Breton, E., & Axel, L. (2010). Rapid B1\u2009+\u2009mapping using a preconditioning RF pulse with TurboFLASH readout. Magnetic resonance in medicine, 64(2), 439\u2013446.","journal-title":"Magnetic resonance in medicine"},{"issue":"5","key":"5428_CR17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/s0022-5347(01)67448-2","volume":"153","author":"CJ Girman","year":"1995","unstructured":"Girman CJ, Jacobsen SJ, Guess HA, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 1995;153(5):1510\u20131515. https:\/\/doi.org\/10.1016\/s0022-5347(01)67448-2.","journal-title":"J Urol"},{"issue":"12","key":"5428_CR18","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamacardio.2024.3486","volume":"9","author":"S Mengi","year":"2024","unstructured":"Mengi S, Januzzi JL Jr, Cavalcante JL, et al. Aortic stenosis, heart failure, and aortic valve replacement. JAMA Cardiol. 2024;9(12):1159\u20131168. https:\/\/doi.org\/10.1001\/jamacardio.2024.3486.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"5428_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","volume":"6","author":"VO Puntmann","year":"2013","unstructured":"Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(4):475\u2013484. https:\/\/doi.org\/10.1016\/j.jcmg.2012.08.019.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"5428_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/ehf2.12865","volume":"7","author":"J Wang","year":"2020","unstructured":"Wang J, Yang F, Wan K, Mui D, Han Y, Chen Y. Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis. ESC Heart Fail. 2020;7(5):2184\u20132192. https:\/\/doi.org\/10.1002\/ehf2.12865.","journal-title":"ESC Heart Fail"},{"issue":"Suppl 5","key":"5428_CR21","doi-asserted-by":"publisher","first-page":"S56-S65","DOI":"10.1002\/nau.24076","volume":"38","author":"R Bosch","year":"2019","unstructured":"Bosch R, Abrams P, Averbeck MA, et al. Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018. Neurourol Urodyn. 2019;38(Suppl 5):S56-S65. https:\/\/doi.org\/10.1002\/nau.24076.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"5428_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/nau.20035","volume":"23","author":"DJ Galvin","year":"2004","unstructured":"Galvin DJ, Watson RW, O\u2019Neill A, et al. Hypoxia inhibits human bladder smooth muscle cell proliferation: a potential mechanism of bladder dysfunction. Neurourol Urodyn. 2004;23(4):342\u2013348. https:\/\/doi.org\/10.1002\/nau.20035.","journal-title":"Neurourol Urodyn"},{"key":"5428_CR23","doi-asserted-by":"publisher","unstructured":"Christ GJ, Liebert M. Proceedings of the Baltimore smooth muscle meeting: identifying research frontiers and priorities for the lower urinary tract. J Urol. 2005;173(4):1406\u20131409. https:\/\/doi.org\/10.1097\/01.ju.0000152289.23797.75.","DOI":"10.1097\/01.ju.0000152289.23797.75"},{"issue":"6","key":"5428_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/nau.20422","volume":"26","author":"N Kebapci","year":"2007","unstructured":"Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26(6):814\u2013819. https:\/\/doi.org\/10.1002\/nau.20422.","journal-title":"Neurourol Urodyn"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05428-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05428-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05428-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:34:44Z","timestamp":1792085684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05428-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5428"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05428-x","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.H., V.G., N.S., H.H., Y.J., and S.W. receive research support from Siemens Healthineers. V.G., Y.J., S.W. receive research support from Cook Medical. S.W. and C.B. are consultants for Ethicon Inc. S.W. receives research support from GE Healthcare and ECO Medical.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}